ProfileGDS2244 / 209205_s_at
TitleMelanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OrganismHomo sapiens


E2F-1 doxorubicin E2F-1 and doxorubicin GSM52504 GSM52508 GSM52518 GSM52519 GSM52516 GSM52517 82% 83% 82% 86% 83% 86% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM52504SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1)252.682
GSM52508SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2)262.683
GSM52518SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1)25282
GSM52519SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2)324.686
GSM52516SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1)253.783
GSM52517SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2)328.586